Nilotinib Responses and Tolerability Confirmed in North American Patients with Chronic Myeloid Leukemia (CML) From ENACT (Expanding Nilotinib Access in Clinical Trials)

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Powell, BL; Khoury, HJ; Lipton, JH; Rizzieri, DA; Williams, D; Turner, AR

Published Date

  • November 20, 2009

Published In

Volume / Issue

  • 114 / 22

Start / End Page

  • 1277 - 1277

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 0006-4971

Conference Name

  • 51st Annual Meeting of the American-Society-of-Hematology

Conference Location

  • New Orleans, LA

Conference Start Date

  • December 5, 2009

Conference End Date

  • December 8, 2009